PT-141 vs Melanotan II
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Bremelanotide, Vyleesi
PT-141, generic name bremelanotide and sold as Vyleesi, is a melanocortin peptide and a cyclic analog of alpha-MSH that works in the brain to boost sexual desire. It is genuinely FDA approved: in June 2019 it became the first on-demand treatment for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. It is also used off-label for low libido and erectile dysfunction in men.
Also: MT-II, MT2
Melanotan II is a synthetic copy of alpha-melanocyte-stimulating hormone (alpha-MSH), nicknamed the tanning peptide because it darkens skin without much sun. It also triggers erections and can blunt appetite, which is why it became the template for the FDA-approved drug bremelanotide (PT-141). Melanotan II itself is not approved by the FDA or EMA and is sold only as an unregulated research chemical.
Key Comparison Insights
- PT-141 is FDA approved, while Melanotan II remains in research stages.
- Both peptides belong to the Sexual Health category, suggesting similar primary applications.
- PT-141 has stronger research evidence (FDA Approved) compared to Melanotan II (Limited Research).
Detailed Comparison
| Attribute | PT-141 | Melanotan II |
|---|---|---|
| Category | Sexual Health | Sexual Health |
| FDA Status | FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Bremelanotide activates melanocortin receptors in the brain, mainly MC4R with some MC3R activity, in the hypothalamus. Unlike PDE5 drugs such as sildenafil that work on blood flow in the genitals, PT-141 acts centrally on the neural circuits that generate sexual desire and arousal, so its effect does not depend on hormone levels or direct physical stimulation. That same MC4R activity is why nausea is its most common side effect, and why it can transiently raise blood pressure and lower heart rate, which shaped its dosing limits. | Melanotan II is a non-selective agonist of the melanocortin receptors, hitting MC1, MC3, MC4, and MC5. Switching on MC1 receptors in skin pigment cells ramps up melanin production, which is the tanning effect. Its sexual effects come from a completely different site: activating MC4 receptors in the brain triggers the neural circuits behind sexual arousal and desire, independent of the vascular plumbing that Viagra-type drugs target. Because it activates so many receptors at once rather than just one, it produces a broad spread of effects and side effects. |
| Common Dosing | 1.75 mg as needed As needed, at least 45 min before activity | 250-500 mcg daily (loading), then 500-1,000 mcg weekly (maintenance) Daily during loading (1-2 weeks), then weekly maintenance |
| Administration | Subcutaneous injection (autoinjector available) | Subcutaneous injection |
| Typical Duration | As needed, at least 45 min before activity | Loading phase 2-3 weeks, then maintenance |
| Best Time to Take | 1-2 hours before sexual activity | Evening or before sun exposure |
Possible Side Effects May vary by individual |
|
|
| Research Summary | PT-141 has some of the strongest evidence of any peptide on the gray market because it went through a full FDA program. The pivotal data come from the two identical phase 3 RECONNECT trials by Kingsberg and colleagues, published in Obstetrics and Gynecology in 2019, which randomized 1,267 premenopausal women with HSDD to 1.75 mg subcutaneous bremelanotide as needed or placebo. Both trials showed statistically significant improvements in sexual desire and in distress over low desire (both P less than 0.001), though the real-world benefit is modest: the effect size on desire scores was roughly 0.3 to 0.6, and the gain in satisfying sexual events over placebo was small. Nausea affected around 40 percent of women and was the leading reason people stopped, and dosing is capped at eight doses per month. Use in men for libido or erectile dysfunction is off-label and far less rigorously studied than the approved female HSDD indication. | Human evidence for Melanotan II is real but narrow and mostly old. A published clinical study in men with organic erectile dysfunction found that the alpha-MSH analog produced subjectively reported erections after 12 of 19 injections versus only 1 of 21 placebo doses, with longer periods of penile rigidity and increased sexual interest, alongside frequent nausea and yawning. That erectogenic finding is exactly what spun off bremelanotide as a regulated drug. The tanning use, by contrast, has no large safety trials behind it, and dermatology sources flag serious concerns: new or changing moles and melanoma reports, uneven or permanent darkening, nausea, and the obvious dangers of injecting an unregulated powder of uncertain purity. Bottom line: it clearly does something at the receptor level, but Melanotan II as sold is an unapproved compound with a thin safety record and known risks, distinct from its approved descendants afamelanotide and bremelanotide. |
Frequently Asked Questions: PT-141 vs Melanotan II
What is the difference between PT-141 and Melanotan II?
PT-141 is a sexual health peptide that pt-141, generic name bremelanotide and sold as vyleesi, is a melanocortin peptide and a cyclic analog of alpha-msh that works in the brain to boost sexual desire. it is genuinely fda approved: in june 2019 it became the first on-demand treatment for acquired, generalized hypoactive sexual desire disorder (hsdd) in premenopausal women. it is also used off-label for low libido and erectile dysfunction in men. Melanotan II is a sexual health peptide that melanotan ii is a synthetic copy of alpha-melanocyte-stimulating hormone (alpha-msh), nicknamed the tanning peptide because it darkens skin without much sun. it also triggers erections and can blunt appetite, which is why it became the template for the fda-approved drug bremelanotide (pt-141). melanotan ii itself is not approved by the fda or ema and is sold only as an unregulated research chemical. The main differences lie in their mechanisms of action and clinical applications.
Which is better, PT-141 or Melanotan II?
Neither is universally "better" - the choice depends on your specific goals. PT-141 is typically used for sexual health purposes, while Melanotan II is used for sexual health. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can PT-141 and Melanotan II be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using PT-141 and Melanotan II together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.